Label Image (Lbl500905147)
Shingrix
Product Images NDC 50090-5147
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Shingrix (NDC 50090-5147). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Shingrix Spl Graphic 01)
The text seems to describe a liquid suspension component used as an adjuvant. However, without additional context or information, it's difficult to provide a more detailed description or use case.*
Figure 2b (Shingrix Spl Graphic 02)
This text describes a lyophilized, or freeze-dried, component of gE antigen in powder form. It likely serves as a diagnostic or research tool for detecting antibodies to gE antigen.*
Figure 3 (Shingrix Spl Graphic 03)
Figure 4 (Shingrix Spl Graphic 04)
This text indicates that there is a reconstituted vaccine available and the recommended dose is 0.5mL.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
